Marker Therapeutics, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2014 | — | $-1.0M | — |
| FY2015 | — | $-21.4M | — |
| FY2016 | — | $6.2M | — |
| FY2017 | — | $3.7M | $5.1M |
| FY2018 | — | $59.3M | $61.7M |
| FY2019 | — | $44.1M | $43.9M |
| FY2020 | — | $27.3M | $21.4M |
| FY2021 | — | $44.0M | $42.4M |
| FY2022 | — | $19.6M | $11.8M |
| FY2023 | — | $14.1M | $15.1M |